Evaluation the prognostic of SPECT in post myocardial infarct
Main Article Content
Abstract
Aims: The purpose of our study was to evaluate the prognostic value of characteristics of defects in Tc99m-sestamibi gated SPECT myocardial perfusion imaging (MPI) in post-MI patients.
Subjects and methods: 116 post-myocardial infarction (MI) patients were underwent gated SPECT in Nuclear Medicine
Department, 108 Central Military Hospital from March 2007 to May 2010. Mean follow-up time was 23.27 ± 9,9 months.
Results: The reversible perfusion defects had higher rate of patients with unstable angina (92.1% vs 76.9%, p<0.05) and
revascularization (95.8% vs 72.1%, p<0.01), respectively. The fixed defect had higher rate of patients with congestive heart failure compared to patient group without congestive heart failure (47.2% vs 6.1%, p<0.001). In patients with unstable angina (UA) and/or recurrent MI, severe and large defects were significant highger than that of patients without UA and/or recurrent MI (p<0.05). In congestive heart failure (CHF) patients, severe and large defects were 97.1% and 76.8% in comparison with 88.2% and 70.7% respectively (p < 0.05). In fatal patient group, 100% had large defects compared to 72% in non-fatal MI patients. SSS and SRS were higher in post-MI patient with coronary events compared to those without coronary events (18.17 ± 5.3 vs 13.5 ± 3.65, p<0.001 and 14.77 ± 5.46 vs 11.04 ± 3.58, p < 0.01).
Conclusions: the characteristics of myocardial perfusion defect on MPI have prognostic value in post-MI patients.
Article Details
References
2. Acampa W., Spinelli L., Petretta M. et al (2005), “Prognostic Value of Myocardial Ischemia in Patiens with Uncomplicated Acute Myocardial Infarction: Direct Comparison of Stress Echocardiography and Myocardial Perfusion Imaging”, J Nucl Med, 46: 417-423.
3. Brown K.A., Heller G.V., Landin R.S. et al (1999), “Early Dipyridamole 99mTc-Sestamibi Single Photon Emission Computed Tomographic Imaging 2 to 4. Days After Acute Myocardial Infarction Predicts In-Hospital and Postdischarge Cardiac Events Comparison With Submaximal Exercise
Imaging”, Circulation; 100: pp.2060-2066.
5. Hansen Ch.L., Goldstein R.A., Akinboboye O.O. et al (2007), “ASNC Imaging Guidelines For Nuclear Cardiology Procedures: Myocardial perfusion
and function: Single photon emission computed tomography”, J Nucl Cardiol; 14:e39-60.
6. Kaya E., Entok E., Cavusoglu Y. et al (2008), “Short – Term Prognostic Value of Rest Tc 99m – MIBI Gated SPECT After Acute Non – Q Wave yocardial Infarction”, Eur J Gen Med;5(3): pp.170-177.
7. Lloyd-Jones D., Adams R.J., Brown T.M. et al (2010), ”Heart Disease and Stroke Statistics—2010 Update: A Report From the American Heart Association, Circulation; 121: pp.e46-e215.
8. Mahmarian J.J., Shaw L.J., Filipchuk N.G. et al (2006), “A Multinational Study to Establish the Value of Early Adenosine Technetium-99m Sestamibi Myocardial Perfusion Imaging in Identifying a Low-Risk Group for Early Hospital Discharge After Acute Myocardial Infarction” , J Am Coll Cardiol, 48: pp.2448 –57.
9. Mahmarian J.J., Dwivedi G., Lahiri T. (2004), “Role of nuclear cardiac imaging in myocardial infarction: Postinfarction risk stratification”, J Nucl Cardiol;11: pp.186-209.
10. Udelson JE, Flint EJ (2004) “Radionuclide imaging in risk assessment after acute coronary syndromes”. Heart; 90 (Suppl V): pp.v16-v25.
11. Zellweger M.J., Dubois E.A., Lai S. et al (2002), “Risk stratification in patients with remote prior myocardial infarction using rest-stress myocardial perfusion SPECT: Prognostic value and impact on referral to early catheterization”, J Nucl Cardiol; 9: pp.23-32.